Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come

(2010) L. T. Ford et al.   JOURNAL OF CLINICAL PATHOLOGY

Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism

(2010) Mary V Relling et al.   LANCET ONCOLOGY

Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?

(2010) Jenny E Higgs et al.   PHARMACOGENOMICS

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

(2009) David Gurwitz et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Variation in Care in Pediatric Crohn Disease

(2009) Richard B Colletti et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia

(2009) K Schmiegelow et al.   LEUKEMIA

Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

(2008) G Stocco et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

(2008) K Schmiegelow et al.   LEUKEMIA